Evernorth Specialty Management

Solutions

Uncovering Behind-the-Scenes Challenges in Bringing Gene Therapies to Market

Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.

Mary Dorholt, PharmD, June 07, 22

Gene Therapies 101

We answer our clients’ burning questions about gene therapies, including how they work, whether or not they’re safe, and if we’ll see more in the future.

Mary Dorholt, PharmD, February 12, 20

Understanding Gene Modification and Cellular Therapies

Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology

Mary Dorholt, PharmD, June 02, 21

We’re on the Verge of a Breakthrough for Gene Therapies

The first gene therapies have come to market. Hundreds more are in the drug pipeline.

Mary Dorholt, PharmD, July 08, 21

How to Have a Data-Driven Discussion on Gene and Cellular Therapies

As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.

Mary Dorholt, PharmD, October 28, 21

Gene Therapy: Proper Care for This Life-Saving Innovation

Evernorth is focused on providing appropriate clinical and financial management for gene therapies coming to market.

July 27, 20

Ensuring Coverage is Key For Life Altering Gene Therapies

Access, cost can be insurmountable hurdles unless the patient’s plan has the proper strategies in place

Jackie Huntebrinker, August 19, 21

Three Specialty Drug Trends to Prepare for: Biosimilars, Gene and Cell Therapies, Cancer Drugs

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...

Harold Carter, April 20, 22